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Treating Viral Respiratory Tract Infections with Antibiotics in Hospitals: No
Longer a Case of Mistaken Identity
Abstract
Widespread use of antibiotics in hospitalized patients contributes to the development of multidrug
resistant organisms that make many infections increasingly difficult to treat. Despite calls to prescribe
antibiotics judiciously, many physicians continue to order antibiotics for inpatients who do not need them.
This Issue Brief investigates antibiotic use in hospitalized adults with a confirmed viral infection, a group
of patients that may not benefit from such therapy. Understanding the factors that lead to inappropriate
antibiotic use may help change clinical practice and limit antibiotic resistance.
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Treating Viral Respiratory Tract Infections
with Antibiotics in Hospitals:
No Longer a Case of Mistaken Identity
Editor’s note: Widespread use of antibiotics in hospitalized patients
contributes to the development of multidrug resistant organisms that make
many infections increasingly difficult to treat. Despite calls to prescribe
antibiotics judiciously, many physicians continue to order antibiotics for
inpatients who do not need them. This Issue Brief investigates antibiotic use
in hospitalized adults with a confirmed viral infection, a group of patients
that may not benefit from such therapy. Understanding the factors that lead
to inappropriate antibiotic use may help change clinical practice and limit
antibiotic resistance.

Widespread antibiotic use in the treatment of hospitalized patients
promotes the development of antibiotic resistance. A recent study of U.S.
teaching hospitals found that 63.5 % of patients discharged in 2006 had
received at least one dose of an antibacterial drug. It is estimated that about
30% of antibiotic-days for hospitalized adults are unnecessary.
• One area where antibiotic use could be limited is in the treatment of
patients with viral respiratory tract infections (RTIs). Patients who
present with acute respiratory symptoms are often prescribed antibiotics
on admission before it is clear whether their illness is viral or bacterial in
origin. Antibiotics are not effective in treating viral infections.
• Recently, highly accurate tests have been developed to identify several
respiratory infections, including influenza A and B, parainfluenza,
adenovirus, and respiratory syncytial virus (RSV). These tests now make
it possible for clinicians to confirm viral causes for illnesses that might
otherwise be mistaken for bacterial infections.
• Despite this theoretical advantage, it is unclear whether improved
diagnosis of viral RTIs has actually led to reduced antibiotic use in
hospitalized adults.

Study investigates
antibiotic use in hospitalized
patients with viral
respiratory infections

The investigators conducted a retrospective analysis of antibiotic use among
newly hospitalized patients admitted with acute respiratory symptoms who
subsequently received a diagnosis of viral RTI.
• All patients were admitted to one of two hospitals affiliated with the
University of Pennsylvania Health System between November 1, 2005
and August 1, 2007. Patients with confirmed viral RTI were identified
through the records of the lab that performs viral diagnostics for the
health system.
• Hospital medical records were reviewed to exclude patients with a
documented bacterial infection within or outside the respiratory tract.
Antibiotic use was ascertained from the hospitals’ electronic medication
ordering system.
• The study included 196 patients with viral RTI. More than 70% of
them had influenza, 15% had RSV, 7% had adenovirus, and 6% had a
parainfluenza virus.

Many patients were
prescribed antibiotics on
admission, and almost all
stayed on antibiotics after
a viral respiratory tract
infection was confirmed

The analysis revealed that antibiotic use in patients with confirmed viral
RTI was common. The decision to stop antibiotic therapy was rare.
Radiographic evidence that caused concern about pneumonia was the
strongest predictor of continued antibiotic use.
• Of the 196 patients, 131 (67%) began antibiotic therapy, and 125
(64%) continued to receive antibiotics after the diagnosis of viral RTI.
The average time from admission to viral RTI diagnosis was one day.
For patients given antibiotics, the median duration of antibiotic use
was 8 days.
• The only anti-viral drug used, oseltamivar, was prescribed for a small
percentage (21%) of patients with influenza; half of these patients
continued to receive antibiotics in addition.
• Forty-six (37%) of the 125 patients who continued to receive
antibiotics had abnormal chest radiographs on admission.
Concern about concomitant bacterial pneumonia in these patients
might prompt clinicians to continue antibiotic therapy. After adjusting
for other possible factors, patients with abnormal chest imaging on
admission were four times as likely to use antibiotics as those with
negative chest imaging.
• However, the majority of patients who were prescribed antibiotics had
normal radiographs. Possible factors that might have led clinicians to
use antibiotics, such as patient age, presenting signs, symptoms, and
comorbid conditions, were not associated with continuation.
The reasons for continuing antibiotic treatment in these patients were
not apparent.

Patients on antibiotics
did not seem to benefit
from this treatment

The study looked at a number of patient outcomes and complications in
patients given antibiotics. Although the study was not designed to detect
small differences in outcomes, the results indicate that the patients who
continued on antibiotics fared no better than those who did not, and some
might have been harmed by the treatment.
• Median length of hospital stay was 5 days for patients on antibiotics,
compared with 3 days for patient not given antibiotics after receiving a
diagnosis of viral RTI. In-hospital mortality was higher in the antibiotic
continuation group (10 vs. 0 deaths). These findings do not suggest
that antibiotics were the cause of the increased length of hospitalization
or the cause of the higher death rate. Patients who were very sick
might have been more likely to receive antibiotics in an overly cautious
approach to their care. And because these patients were sicker, they were
also more likely to have long hospitalizations and higher mortality.
• However, eight patients (6%) who continued antibiotic therapy
developed diarrhea from C. difficile infection, compared to
0 patients not on antibiotics. This is a well-established risk of antibiotic
use. Here, the causal link between antibiotic use and complications is
more plausible.
• Patients who continued on antibiotics were more likely to be
rehospitalized within 30 days of discharge, although the study was too
small to determine whether this result was simply due to chance.

POLICY IMPLICATIONS

These data demonstrate at least one area where antibiotics are commonly
used in hospitalized patients without clear reason. The study did not reveal
any clinical benefit to continuing antibiotics once a viral RTI is confirmed.
In some cases, it might have led to harm.
• The findings could be useful in targeting interventions to limit
the use of unnecessary antibiotics among inpatients. An antibiotic
stewardship program might be beneficial in targeting patients who
receive a diagnosis of viral RTI. One approach might be a voluntary or
mandatory antibiotic “time-out” in which the physician reassesses the
need for antibiotics when the results are received.
• Although antibiotics may have been used to prevent a secondary
bacterial infection, there are few data to support such practice. In
contrast to antibiotic use, an effective antiviral treatment for influenza
was used in a small minority of patients with confirmed influenza.
• Further research is needed to understand these clinical practice patterns.
It is possible that physician anxiety over concurrent or developing
bacterial infection is the reason. If so, then educational programs
may help alleviate this concern and reduce overuse of antibiotics in
hospitalized patients.
Continued on next page.

POLICY IMPLICATIONS
(cont’d)

•

These data should bolster ongoing efforts to limit inappropriate
antibiotic use. The Centers for Disease Control and Prevention
has launched Get Smart for Healthcare, a new campaign focused on
improving antibiotic use in inpatient healthcare settings through the
implementation of antibiotic stewardship programs. These programs are
interventions designed to ensure that hospitalized patients receive the
right antibiotic at the right time.
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